# Anesthesia and Cancer Study: Renal Cell Carcinoma

> **NCT04503148** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 562 (estimated)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DRUG:** Propofol
- **DRUG:** Inhaled General Anesthetics

## Key facts

- **NCT ID:** NCT04503148
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-09-22
- **Primary completion:** 2022-12-22
- **Final completion:** 2025-12-22
- **Target enrollment:** 562 (ESTIMATED)
- **Last updated:** 2024-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04503148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04503148, "Anesthesia and Cancer Study: Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04503148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*